US Stock MarketDetailed Quotes

CYCC Cyclacel Pharmaceuticals

Watchlist

0.3473
-0.0240-6.46%

Close Nov 21 16:00 ET

2.18MMarket Cap-12P/E (TTM)

Cyclacel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-37.50%10K

-98.93%4K

29K

420K

31K

16K

373K

Operating revenue

-37.50%10K

-98.93%4K

--29K

--420K

--31K

--16K

--373K

--0

Cost of revenue

Gross profit

Operating expense

-68.12%2.19M

-42.11%3.65M

-40.10%4.38M

-6.45%25.87M

-39.05%5.39M

6.09%6.86M

8.94%6.3M

11.59%7.32M

23.52%27.66M

47.79%8.85M

Selling and administrative expenses

-23.88%1.24M

3.17%1.63M

-3.83%1.58M

-8.99%6.72M

-12.60%1.87M

-20.89%1.63M

-0.32%1.58M

2.49%1.65M

-1.06%7.38M

10.41%2.14M

-General and administrative expense

-23.88%1.24M

3.17%1.63M

-3.83%1.58M

-8.99%6.72M

-12.60%1.87M

-20.89%1.63M

-0.32%1.58M

2.49%1.65M

-1.06%7.38M

10.41%2.14M

Research and development costs

-81.86%950K

-57.20%2.02M

-50.62%2.8M

-5.52%19.16M

-47.51%3.52M

18.65%5.24M

12.41%4.73M

14.53%5.67M

35.81%20.27M

65.73%6.7M

Operating profit

68.20%-2.18M

38.54%-3.64M

40.50%-4.36M

7.97%-25.45M

39.40%-5.36M

-5.85%-6.85M

-2.49%-5.93M

-11.59%-7.32M

-23.52%-27.66M

-47.79%-8.85M

Net non-operating interest income expense

-84.00%8K

-136.36%-28K

-98.28%2K

26.67%266K

-81.15%23K

-25.37%50K

352.94%77K

2,800.00%116K

1,212.50%210K

2,950.00%122K

Non-operating interest income

-84.00%8K

----

-98.28%2K

26.67%266K

-81.15%23K

-25.37%50K

352.94%77K

2,800.00%116K

1,212.50%210K

2,950.00%122K

Non-operating interest expense

----

--28K

----

Other net income (expense)

-97.89%2K

101.65%3K

-32.91%53K

-123.78%-364K

-28.52%-356K

-67.24%95K

-187.08%-182K

-93.96%79K

714.36%1.53M

-810.26%-277K

Gain on sale of security

-98.08%2K

103.95%3K

101.15%1K

-277.68%-414K

-26.69%-356K

-62.32%104K

-136.36%-76K

-400.00%-87K

429.55%233K

-820.51%-281K

Other non- operating income (expenses)

----

-68.67%52K

-96.15%50K

--0

-164.29%-9K

---106K

-87.03%166K

801.39%1.3M

--4K

Income before tax

67.66%-2.17M

39.19%-3.67M

39.64%-4.3M

1.40%-25.55M

36.74%-5.69M

-9.66%-6.7M

-8.54%-6.03M

-35.80%-7.12M

-16.81%-25.92M

-51.46%-9M

Income tax

68.56%-210K

29.69%-412K

-2.58%-1.35M

36.49%-3M

73.31%-422K

34.12%-668K

40.45%-586K

-15.99%-1.32M

-26.53%-4.72M

-46.66%-1.58M

Net income

67.56%-1.96M

40.22%-3.26M

49.24%-2.95M

-6.40%-22.56M

28.95%-5.27M

-18.37%-6.03M

-19.08%-5.45M

-41.29%-5.8M

-14.85%-21.2M

-52.53%-7.42M

Net income continuous Operations

67.56%-1.96M

40.22%-3.26M

49.24%-2.95M

-6.40%-22.56M

28.95%-5.27M

-18.37%-6.03M

-19.08%-5.45M

-41.29%-5.8M

-14.85%-21.2M

-52.53%-7.42M

Minority interest income

Net income attributable to the parent company

67.56%-1.96M

40.22%-3.26M

49.24%-2.95M

-6.40%-22.56M

28.95%-5.27M

-18.37%-6.03M

-19.08%-5.45M

-41.29%-5.8M

-14.85%-21.2M

-52.53%-7.42M

Preferred stock dividends

0.00%201K

0.00%50K

0.00%201K

0.00%50K

Other preferred stock dividends

Net income attributable to common stockholders

67.82%-1.96M

40.76%-3.26M

49.68%-2.95M

-6.34%-22.76M

28.76%-5.32M

-18.19%-6.08M

-18.88%-5.5M

-40.79%-5.85M

-14.69%-21.4M

-51.99%-7.47M

Basic earnings per share

62.50%-0.18

89.04%-0.72

67.57%-2.27

6.79%-26.75

30.78%-6.23

92.56%-0.48

4.78%-6.57

-11.11%-7

8.45%-28.7

-11.11%-9

Diluted earnings per share

62.50%-0.18

89.04%-0.72

67.57%-2.27

6.79%-26.75

30.78%-6.23

92.56%-0.48

4.78%-6.57

-11.11%-7

8.45%-28.7

-11.11%-9

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	-37.50%10K	-98.93%4K	29K	420K	31K	16K	373K	0	0	0
Operating revenue	-37.50%10K	-98.93%4K	--29K	--420K	--31K	--16K	--373K	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-68.12%2.19M	-42.11%3.65M	-40.10%4.38M	-6.45%25.87M	-39.05%5.39M	6.09%6.86M	8.94%6.3M	11.59%7.32M	23.52%27.66M	47.79%8.85M
Selling and administrative expenses	-23.88%1.24M	3.17%1.63M	-3.83%1.58M	-8.99%6.72M	-12.60%1.87M	-20.89%1.63M	-0.32%1.58M	2.49%1.65M	-1.06%7.38M	10.41%2.14M
-General and administrative expense	-23.88%1.24M	3.17%1.63M	-3.83%1.58M	-8.99%6.72M	-12.60%1.87M	-20.89%1.63M	-0.32%1.58M	2.49%1.65M	-1.06%7.38M	10.41%2.14M
Research and development costs	-81.86%950K	-57.20%2.02M	-50.62%2.8M	-5.52%19.16M	-47.51%3.52M	18.65%5.24M	12.41%4.73M	14.53%5.67M	35.81%20.27M	65.73%6.7M
Operating profit	68.20%-2.18M	38.54%-3.64M	40.50%-4.36M	7.97%-25.45M	39.40%-5.36M	-5.85%-6.85M	-2.49%-5.93M	-11.59%-7.32M	-23.52%-27.66M	-47.79%-8.85M
Net non-operating interest income expense	-84.00%8K	-136.36%-28K	-98.28%2K	26.67%266K	-81.15%23K	-25.37%50K	352.94%77K	2,800.00%116K	1,212.50%210K	2,950.00%122K
Non-operating interest income	-84.00%8K	----	-98.28%2K	26.67%266K	-81.15%23K	-25.37%50K	352.94%77K	2,800.00%116K	1,212.50%210K	2,950.00%122K
Non-operating interest expense	----	--28K	----	----	----	----	----	----	----	----
Other net income (expense)	-97.89%2K	101.65%3K	-32.91%53K	-123.78%-364K	-28.52%-356K	-67.24%95K	-187.08%-182K	-93.96%79K	714.36%1.53M	-810.26%-277K
Gain on sale of security	-98.08%2K	103.95%3K	101.15%1K	-277.68%-414K	-26.69%-356K	-62.32%104K	-136.36%-76K	-400.00%-87K	429.55%233K	-820.51%-281K
Other non- operating income (expenses)	----	----	-68.67%52K	-96.15%50K	--0	-164.29%-9K	---106K	-87.03%166K	801.39%1.3M	--4K
Income before tax	67.66%-2.17M	39.19%-3.67M	39.64%-4.3M	1.40%-25.55M	36.74%-5.69M	-9.66%-6.7M	-8.54%-6.03M	-35.80%-7.12M	-16.81%-25.92M	-51.46%-9M
Income tax	68.56%-210K	29.69%-412K	-2.58%-1.35M	36.49%-3M	73.31%-422K	34.12%-668K	40.45%-586K	-15.99%-1.32M	-26.53%-4.72M	-46.66%-1.58M
Net income	67.56%-1.96M	40.22%-3.26M	49.24%-2.95M	-6.40%-22.56M	28.95%-5.27M	-18.37%-6.03M	-19.08%-5.45M	-41.29%-5.8M	-14.85%-21.2M	-52.53%-7.42M
Net income continuous Operations	67.56%-1.96M	40.22%-3.26M	49.24%-2.95M	-6.40%-22.56M	28.95%-5.27M	-18.37%-6.03M	-19.08%-5.45M	-41.29%-5.8M	-14.85%-21.2M	-52.53%-7.42M
Minority interest income
Net income attributable to the parent company	67.56%-1.96M	40.22%-3.26M	49.24%-2.95M	-6.40%-22.56M	28.95%-5.27M	-18.37%-6.03M	-19.08%-5.45M	-41.29%-5.8M	-14.85%-21.2M	-52.53%-7.42M
Preferred stock dividends				0.00%201K	0.00%50K	0.00%50K	0.00%50K	0.00%50K	0.00%201K	0.00%50K
Other preferred stock dividends
Net income attributable to common stockholders	67.82%-1.96M	40.76%-3.26M	49.68%-2.95M	-6.34%-22.76M	28.76%-5.32M	-18.19%-6.08M	-18.88%-5.5M	-40.79%-5.85M	-14.69%-21.4M	-51.99%-7.47M
Basic earnings per share	62.50%-0.18	89.04%-0.72	67.57%-2.27	6.79%-26.75	30.78%-6.23	92.56%-0.48	4.78%-6.57	-11.11%-7	8.45%-28.7	-11.11%-9
Diluted earnings per share	62.50%-0.18	89.04%-0.72	67.57%-2.27	6.79%-26.75	30.78%-6.23	92.56%-0.48	4.78%-6.57	-11.11%-7	8.45%-28.7	-11.11%-9
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data